For example, the proteoglycan glypican-1 positive (GPC1+) exosomes derived from the serum of pancreas cancer patients could distinguish early- and late-stage pancreas cancer as well as patients with a benign pancreas disease [30]. This evidence concerns the gene GPC1 and pancreatic neoplasm.